An update on Chagas disease (human American trypanosomiasis)

Annals of Tropical Medicine and Parasitology

Volumn 100, Issue 8, 2006, Pages 663-677

  Moncayo, A ^a   Ortiz Yanine, M I ^a  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; BENZNIDAZOLE; INSECTICIDE; NIFURTIMOX; POSACONAZOLE; PYRETHROID;

BLOOD TRANSFUSION; CHAGAS DISEASE; DISEASE COURSE; DISEASE TRANSMISSION; DRUG WITHDRAWAL; EPIDEMIOLOGICAL DATA; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; INFECTION CONTROL; LABORATORY DIAGNOSIS; NONHUMAN; PATHOGENESIS; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SERODIAGNOSIS; TRYPANOSOMA CRUZI; UNSPECIFIED SIDE EFFECT;

ANIMALS; CENTRAL AMERICA; CHAGAS DISEASE; ENDEMIC DISEASES; FEMALE; HEALTH POLICY; HUMANS; INSECT VECTORS; MALE; PREVALENCE; SOUTH AMERICA; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 34250635871     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485906X112248     Document Type: Review

References (50)

1. Aché, A. & Matos, A. (2001). Interrupting Chagas disease transmission in Venezuela. Revista do Instituto de Medicina Tropical de São Paulo, 43, 37-43.
2. Andrade, A. L., Zicker, F., Oliveira, R. M., Silva, S. A., Luquetti, A., Trabaos, L. R., Almeida, I. C., Andrade, S. S., Andrade, J. G. & Martelli, C. M. T. (1996). Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet, 348, 1407-1413.
3. Andrade, S. G. (1974). Caracterização de cepas do Trypanosoma cruzi isoladas do Recôncavo Baiano. Revista de Patologia Tropical, 3, 65-121.
4. Andrade, Z. (2000). Patologia da doenca de Chagas. In Trypanosoma cruzi e Doença de Chagas, eds Brener, Z., Andrade, Z. A. & Barral-Neto, M. pp. 201-230. Rio de Janeiro, Brazil: Guanabara-Koogan.
5. Añez, N., Carrasco, H., Parada, H., Crisante, G., Rojas, A., Fuenmayor, C., Gonzalez, N. Percoco, G., Borges, R., Guevara, P. & Ramirez, J. L. (1999). Myocardial parasite persistence in chronic chagasic patients. American Journal of Tropical Medicine and Hygiene, 60, 726-732.
6. Anon. (1991). Reunión de Ministros de Salud del MERCOSUR, Brasilia, Junio 1991, Resolución 04-3-CS. Montevideo: Mercado Común del Sur.
7. Chagas, C. (1909). Nova tripanozomiase humana. Estudos sobre a morfolojía e o ciclo evolutivo de Schizotrypanum cruzi n.gen., n.sp., ajente etiolójico de nova entidade morbida do homen. Memórias do Instituto Oswaldo Cruz, 1, 159-218.
8. Coura, J. R., Abreu, L. L., Pereira, J. B. & Willcox, H. P. F. (1985). Morbidade da doenca de Chagas, IV. Estudo longitudinal de dez anos em Pains e Iguatama, Minas Gerais, Brasil. Memórias do Instituto Oswaldo Cruz, 80, 73-80.
9. Di Noia, J. M., d'Orso, I., Åslund, L., Sánchez, D. O. & Frasch, A. C. C. (1998). The Trypanosoma cruzi mucin family is transcribed from hundreds of genes having hypervariable regions. Journal of Biological Chemistry, 273, 10,843-10,850.
10. El-Sayed, N. M., Myler, P. J., Bartholomeu, D. C., Nilsson, D., Aggarwal, G., Tran, A. N., Ghedin, E., Worthey, E. A., Delcher, A. L., Blandin, G., Westenberger, S. J., Caler, E., Cerqueira, G. C., Branche, C., Haas, B., Anupama, A., Arner, E., Aslund, L., Attipoe, P., Bontempi, E., Bringaud, F., Burton, P., Cadag, E., Campbell, D. A., Carrington, M., Crabtree, J., Darban, H., da Silveira, J. F., de Jong, P., Edwards, K., Englund, P. T., Fazelina, G., Feldblyum, T., Ferella, M., Frasch, A. C., Gull, K., Horn, D., Hou, L., Huang, Y., Kindlund, E., Klingbeil, M., Kluge, S., Koo, H., Lacerda, D., Levin, M. J., Lorenzi, H., Louie, T., Machado, C. R., McCulloch, R., McKenna, A., Mizuno, Y., Mottram, J. C., Nelson, S., Ochaya, S., Osoegawa, K., Pai, G., Parsons, M., Pentony, M., Pettersson, U., Pop, M., Ramirez, J. L., Rinta, J., Robertson, L., Salzberg, S. L., Sanchez, D. O., Seyler, A., Sharma, R., Shetty, J., Simpson, A. J., Sisk, E., Tammi, M. T., Tarleton, R., Teixeira, S., Van Aken, S., Vogt, C., Ward, P. N., Wickstead, B., Wortman, J., White, O., Fraser, C. M., Stuart, K. D. & Andersson, B. (2005). The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science, 309, 409-415.
11. Fernandes, O., Souto, J. A., Castro, J. B., Pereira, N. C., Fernandes, A. C., Junqueira, R. D., Naiff, T. V., Barrett, W., Degrave, W., Zingales, B., Campbell, D. A. & Coura, J. R. (1998). Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exon and ribosomal RNA sequences. American Journal of Tropical Medicine and Hygiene, 58, 807-811.
12. Grant, I. H., Gold, J. W. & Winner, M. (1989). Transfusion-associated acute Chagas disease acquired in the United States. Annals of Internal Medicine, 111, 849-851.
13. Guhl, F. & Schofield, C. J. (eds) (2004). Proceedings of an International Workshop on Chagas Disease Surveillance in the Amazon Region. Bogota: Universidad de Los Andes.
14. Hanke, J., Frohme, M., Laurent, J. P., Swindle, J. & Hoheisel, J. D. (1998). Hybridization mapping of Trypanosoma cruzi chromosomes III and IV. Electrophoresis, 4, 482-485.
15. Henriksson, J., Porcel, B., Rydaker, M., Ruiz, A., Sabaj, V., Galanti, N., Cazzulo, J. J., Frasch, A. C. & Pettersson, U. (1995). Chromosome specific markers reveal conserved linkage groups in spite of extensive chromosomal size variation in Trypanosoma cruzi. Molecular Biochemistry and Parasitology, 73, 63-74.
16. Higuchi, M. L., Gutiérrez, P., Aiello, V. D., Palomino, S., Bocchi, E. A., Kalil, J., Bellotti, G. & Pileggi, F. (1993). Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Archiv, 423, 157-160.
17. Higuchi, M. L., Ries, M. M., Aiello, V. D., Benvenuti, L. A., Gutierrez, P. S., Bellotti, G. & Pileggi, F. (1997). Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. American Journal of Tropical Medicine and Hygiene, 56, 485-489.
18. Jones, E. M., Colley, D. G., Tostes, S., Lopes, E. R., Vnencak-Jones, C. L. & McCurley, T. L. (1992). A Trypanosoma cruzi DNA sequence amplified from inflammatory lesions in human chagasic cardiomyopathy. Transactions of the Association of American Physicians, 105, 182-189.
19. Kierszenbaum, F. (1999). Chagas' disease and the autoimmunity hypothesis. Clinical Microbiology Reviews, 12, 210-223.
20. Kirchhoff, L., Gamm, A. A. & Gilliam, F. C. (1987). American trypanosomiasis (Chagas disease) in Central American immigrants. American Journal of Medicine, 82, 915.
21. Liendo, A., Lazardi, K. & Urbina, J. A. (1998). In vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. Journal of Antimicrobial Chemotherapy, 41, 197-205.
22. Miles, M. A., Lanham, S. M., Souza, A. A. & Povoa, M. (1980). Further enzymic characters of Trypanosoma cruzi and their evaluation for strain identification. Transactions of the Royal Society of Tropical Medicine and Hygiene, 74, 221-242.
23. Moncayo, A. & Luquetti, A. O. (1990). Multicentric double blind study for evaluation of Trypanosoma cruzi defined antigens as diagnostic reagents. Memórias do Instituto Oswaldo Cruz, 85, 489-495.
24. Morel, C. M., Chiari, E., Plessmann Camargo, E., Mattei, D. M., Romanha, A. J. & Simpson, L. (1980). Strains and clones of Trypanosoma cruzi can be characterized by restriction endonuclease fingerprinting of kinetoplast DNA minicircles. Proceedings of the National Academy of Sciences of the United States of America, 77, 6810-6814.
25. Morel, C. M., Acharya, T., Broun, D., Dangi, A., Elias, C., Ganguly, N. K., Gardner, C. A., Gupta, R. K., Haycock, J., Heher, A. D., Hotez, P. J., Kettler, H. E., Keusch, G. T., Krattiger, A. F., Kreutz, F. T., Lall, S., Lee, K., Mahoney, R., Martinez-Palomo, A., Mashelkar, R. A., Matlin, S. A., Mzimba, M., Oehler, J., Ridley, R. G., Senanayake, P., Singer, P. & Yun, M. (2005). Health innovation network to help developing countries address neglected diseases. Science, 309, 401-404.
26. Muñoz, P., Thiermann, E., Attias, A. & Acevedo, C. (1992). Enfermedad de Chagas congénita sintomática en recién nacidos y lactantes. Revista Chilena de Pediatria, 65, 196-202.
27. Pan American Health Organization (1999). Tratamiento Etiológico de la Enfermedad de Chagas, Conclusiones de una Consulta Técnica. Document PS/HCP/HCT/140/99. Washington, DC: PAHO.
28. Pereira, J. B., Willcox, H. P. & Coura, J. R. (1985). Morbidade da doenca de Chagas. III. Estudo longitudinal de seis anos, em Virgen da Lapa, MG, Brasil. Memórias do Instituto Oswaldo Cruz, 80, 63-71.
29. Reis, D. D., Jones, E. M., Tostes, S., Lopes, E. R., Chapadeiro, E., Gazinelli, G., Colley, D. G. & McCurley, T. L. (1993). Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-_+ cells and dominance of granzyme A+ , CD8+ lymphocytes. American Journal of Tropical Medicine and Hygiene, 48, 637-644.
30. Rezende, J. M. & Luquetti, A. O. (1994). Chagasic megavisceras. In Chagas' Disease and the Nervous System, pp. 149-171. Scientific Publication No. 547. Washington, DC: Pan American Health Organization.
31. Russomando, G., Tomassone, M. M., Guillen, I., Acosta, N., Vera, N., Almiron, M., Candia, N., Calcena, M. F. & Figueredo, A. (1998). Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. American Journal of Tropical Medicine and Hygiene, 59, 487-491.
32. Schmunis, G. A. (1991). Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and non endemic countries. Transfusion, 31, 547-557.
33. Sica, R. E. P. (1986). Involvement of the peripheral sensory nervous system in human chronic Chagas disease. Medicina, 46, 662-668.
34. Sosa Estani, S., Segura, E. L., Ruiz, A. M., Velásquez, E., Porcel, B. M. & Yampotis, C. (1998). Chemotherapy with benznidazole in children in undeterminated phase of Chagas disease. American Journal of Tropical Medicine and Hygiene, 59, 526-529.
35. Souto, R. P., Fernandes, O., Macedo, A. M., Campbell, D. A. & Zingales, B. (1996). DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Molecular and Biochemical Parasitology, 83, 141-152.
36. Tibayrenc, M. (1995). Population genetics of parasitic protozoa and other microorganisms. Advances in Parasitology, 36, 47-115.
37. Tostes Jr, S., Lopes, E. R., Pereira, F. E. L. & Chapadeiro, E. (1994). Miocardite chagásica crônica humana: estudo quantitative dos linfócitos CD4+ e dos CD8+ no exsudato inflamatorio. Revista da Sociedade Brasilera de Medicina Tropical, 27, 127-134.
38. Urbina, J. A. (1999). Chemotherapy of Chagas disease: the how and the why. Journal of Molecular Medicine, 77, 332-338.
39. Vago, A. R. (1996). PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet, 348, 891.
40. Vago, A. R., Andrade, L. O., Leite, A. A., d'Avila Reis, D., Macedo, A. M., Adad, S. J., Tostes Jr, S., Moreira, M. C., Filho, G. B. & Pena, S. D. (2000). Genetic characterization of T. cruzi directly from tissues of patients with chronic Chagas' disease. Differential distribution of genetic types into diverse organs. American Journal of Pathology, 156, 1805-1809.
41. Viotti, R. C., Vigliano, C., Armenti, H. & Segura, E. (1994). Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. American Heart Journal, 127, 151.
42. World Health Organization (1991). Special Programme for Research and Training in Tropical Diseases, Eleventh Programme Report. Geneva: WHO.
43. World Health Organization (1994). Protocolo de evaluación de efecto insecticida sobre Triatominos. Acta Toxicológica Argentina, 2, 29-32.
44. World Health Organization (1998a). 51st World Health Assembly, Resolution WHA51.14. Geneva: WHO.
45. World Health Organization (1998b). Chagas disease. Interruption of transmission in Uruguay. Weekly Epidemiological Record, 73, 1-4.
46. World Health Organization (1999). Chagas disease. Interruption of transmission in Chile. Weekly Epidemiological Record, 74, 9-11.
47. World Health Organization (2000). Chagas disease. Certification of interruption of transmission in Chile. Weekly Epidemiological Record, 75, 10-12.
48. World Health Organization (2002). Report of the Expert Committee on the Control of Chagas Disease. Technical Report Series No. 905. Geneva: WHO.
49. Zingales, B., Pereira, M. E., Oliveira, R. P., Almeida, K. A., Umezawa, E. S., Souto, R. P., Vargas, N., Cano, M. I., da Silveira, J. F., Nehme, N. S., Morel, C. M., Brener, Z. & Macedo, A. (1997). Trypanosoma cruzi genome project: biological characteristics and molecular typing of clone CL Brener. Acta Tropica, 68, 159-173.
50. Zingales, B., Souto, R. P., Mangia, R. H., Lisboa, C. V., Campbell, D. A., Coura, J. R., Jansen, A. & Fernandes, O. (1998). Molecular epidemiology of American trypanosomiasis in Brazil based on dimorphisms of rRNA and mini-exon gene sequences. International, Journal for Parasitology, 28, 105-112.